Detalles de la búsqueda
1.
Transurethral water vapor ablation of the prostate with the Rezum system: Urodynamic findings.
Neurourol Urodyn
; 42(1): 249-255, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335610
2.
Bilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles after Robotic Radical Prostatectomy with Pelvic Lymph Node Dissection-Results of the Prospective Randomized Multicenter Trial ProLy.
J Urol
; 208(2): 333-340, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422136
3.
Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center.
World J Urol
; 40(6): 1419-1425, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348869
4.
Feasibility of robot-assisted radical prostatectomy in men at senior age ≥75 years: perioperative, functional, and oncological outcomes of a high-volume center.
Aging Male
; 25(1): 8-16, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34957914
5.
Muscarinic-3-receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial.
Neurourol Urodyn
; 41(5): 1139-1148, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35419807
6.
Development of a Management Algorithm for Acute and Chronic Radiation Urethritis and Cystitis.
Urol Int
; 106(1): 63-74, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34130300
7.
Perioperative and Postoperative Outcomes of Robot-Assisted Radical Prostatectomy in Prostate Cancer Patients with Prior Transurethral Subvesical Deobstruction: Results of a High-Volume Center.
J Urol
; 206(2): 308-318, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33904761
8.
Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression.
World J Urol
; 39(7): 2635-2643, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33337513
9.
Model-based meta-analysis of the time to first acute urinary retention or benign prostatic hyperplasia-related surgery in patients with moderate or severe symptoms.
Br J Clin Pharmacol
; 87(7): 2777-2789, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33247951
10.
What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine.
Neurourol Urodyn
; 40(6): 1559-1568, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036630
11.
Which drugs are best for overactive bladder? From patients' expectations to physicians' decisions.
Int J Clin Pract
; 75(4): e13870, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33251651
12.
The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
BJU Int
; 126(3): 317-326, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32599656
13.
Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH.
World J Urol
; 38(2): 463-472, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079189
14.
Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms.
Br J Clin Pharmacol
; 86(8): 1585-1599, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32144791
15.
Prevalence of female urinary incontinence in the developing world: A systematic review and meta-analysis-A Report from the Developing World Committee of the International Continence Society and Iranian Research Center for Evidence Based Medicine.
Neurourol Urodyn
; 39(4): 1063-1086, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243626
16.
The International Continence Society (ICS) report on the terminology for male lower urinary tract surgery.
Neurourol Urodyn
; 39(8): 2072-2088, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045121
17.
The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction.
Neurourol Urodyn
; 38(2): 433-477, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30681183
18.
The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder.
Neurourol Urodyn
; 38(3): 996-1004, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30801826
19.
Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?
Int Urogynecol J
; 30(2): 239-244, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29600400
20.
Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making.
BMC Med Inform Decis Mak
; 19(1): 130, 2019 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31296199